-Engaging with patient community and presenting overview of PRESIDIO study at The Myositis Association’s (TMA) International Annual Patient Conference -Scientific poster presentation on MISSION Phase 1b study data at 22nd Pan-American Congress of Rheumatology 2020 (PANLAR 2020) Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing… Read More..

SAN JOSE, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its financial results for the six months ended June 30, 2020. Financial Highlights for the… Read More..

PRINCETON, N.J., Sept. 9, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will… Read More..